Genovis AB (publ.) (GENO) — Capital Reinvestment Ratio
Genovis AB (publ.) (GENO) has a Capital Reinvestment Ratio of 1.00x as of December 2025, meaning it reinvests 1% of its operating cash flow (Skr15.90 Million) in capital expenditures (Skr15.90 Million). See Genovis AB (publ.) balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Genovis AB (publ.) Capital Reinvestment Ratio (2019–2025)
This chart tracks Genovis AB (publ.)'s Capital Reinvestment Ratio across 6 annual periods. Check GENO cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Genovis AB (publ.) (2019–2025)
Year-by-year Capital Reinvestment Ratio for Genovis AB (publ.) from 2019 to 2025. For live market cap and broader valuation context, see Genovis AB (publ.) market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.00x | Skr32.02 Million | Skr32.02 Million | ▲ +3314.5% |
| 2024 | 0.03x | Skr37.12 Million | Skr1.09 Million | ▼ -84.5% |
| 2023 | 0.19x | Skr67.75 Million | Skr12.81 Million | ▲ +93.3% |
| 2021 | 0.10x | Skr45.92 Million | Skr4.49 Million | ▼ -98.2% |
| 2020 | 5.44x | Skr3.76 Million | Skr20.43 Million | ▲ +1285.5% |
| 2019 | 0.39x | Skr13.13 Million | Skr5.15 Million | — |